EcoDrugPlus

Adrenergic Receptor, Alpha 2b

Ensembl ID : ENSPEMG00000007923
Gene Symbol: ADRA2B
1 Cross references
219 Possible Orthologues:

Adrenergic Receptor, Beta 1

Ensembl ID : ENSPEMG00000014645
Gene Symbol: ADRB1
1 Cross references
161 Possible Orthologues:

Adrenergic Receptor, Beta 3

Ensembl ID : ENSPEMG00000007552
Gene Symbol: ADRB3
1 Cross references
215 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSPEMG00000018698
Gene Symbol: ADRA1B
3 Cross references
263 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSPEMG00000024149
Gene Symbol: ADRA1D
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSPEMG00000017638
Gene Symbol: ADRA2A
3 Cross references
230 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSPEMG00000007034
Gene Symbol: ADRA2C
3 Cross references
227 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSPEMG00000018963
Gene Symbol: ADRB2
3 Cross references
263 Possible Orthologues:

Advanced Glycosylation End Product-Specific Receptor

Ensembl ID : ENSPEMG00000013952
Gene Symbol: AGER
1 Cross references
169 Possible Orthologues:

Alcohol Dehydrogenase Class-3

Ensembl ID : ENSPEMG00000024078
Gene Symbol: LOC102917102
3 Cross references
400 Possible Orthologues:

Aldose Reductase

Ensembl ID : ENSPEMG00000022346
Gene Symbol: LOC102913851
3 Cross references
429 Possible Orthologues:

Amiloride-Sensitive Amine Oxidase [Copper-Containing]

Ensembl ID : ENSPEMG00000013298
Gene Symbol: LOC102926390
3 Cross references
203 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).